Development of an enantioselective assay for simultaneous separation of venlafaxine and O-desmethylvenlafaxine by micellar electrokinetic chromatography-tandem mass spectrometry: Application to the analysis of drug-drug interaction.

To-date, there has been no effective chiral capillary electrophoresis-mass spectrometry (CE-MS) method reported for the simultaneous enantioseparation of the antidepressant drug, venlafaxine (VX) and its structurally-similar major metabolite, O-desmethylvenlafaxine (O-DVX). This is mainly due to the difficulty of identifying MS compatible chiral selector, which could provide both high enantioselectivity and sensitive MS detection. In this work, poly-sodium N-undecenoyl-L,L-leucylalaninate (poly-L,L-SULA) was employed as a chiral selector after screening several dipeptide polymeric chiral surfactants. Baseline separation of both O-DVX and VX enantiomers was achieved in 15min after optimizing the buffer pH, poly-L,L-SULA concentration, nebulizer pressure and separation voltage. Calibration curves in spiked plasma (recoveries higher than 80%) were linear over the concentration range 150-5000ng/mL for both VX and O-DVX. The limit of detection (LOD) was found to be as low as 30ng/mL and 21ng/mL for O-DVX and VX, respectively. This method was successfully applied to measure the plasma concentrations of human volunteers receiving VX or O-DVX orally when co-administered without and with indinivar therapy. The results suggest that micellar electrokinetic chromatography electrospray ionization-tandem mass spectrometry (MEKC-ESI-MS/MS) is an effective low cost alternative technique for the pharmacokinetics and pharmacodynamics studies of both O-DVX and VX enantiomers. The technique has potential to identify drug-drug interaction involving VX and O-DVX enantiomers while administering indinivar therapy.

Molecular mechanism of a green-shifted, pH-dependent red fluorescent protein mKate variant.

Fluorescent proteins that can switch between distinct colors have contributed significantly to modern biomedical imaging technologies and molecular cell biology. Here we report the identification and biochemical analysis of a green-shifted red fluorescent protein variant GmKate, produced by the introduction of two mutations into mKate. Although the mutations decrease the overall brightness of the protein, GmKate is subject to pH-dependent, reversible green-to-red color conversion. At physiological pH, GmKate absorbs blue light (445 nm) and emits green fluorescence (525 nm). At pH above 9.0, GmKate absorbs 598 nm light and emits 646 nm, far-red fluorescence, similar to its sequence homolog mNeptune. Based on optical spectra and crystal structures of GmKate in its green and red states, the reversible color transition is attributed to the different protonation states of the cis-chromophore, an interpretation that was confirmed by quantum chemical calculations. Crystal structures reveal potential hydrogen bond networks around the chromophore that may facilitate the protonation switch, and indicate a molecular basis for the unusual bathochromic shift observed at high pH. This study provides mechanistic insights into the color tuning of mKate variants, which may aid the development of green-to-red color-convertible fluorescent sensors, and suggests GmKate as a prototype of genetically encoded pH sensors for biological studies.

Etude de la composition initiale et du vieillissement des traces digitales: vers le développement d'une méthode de datation?

«Quel est l'âge de cette trace digitale?» Cette question est relativement souvent soulevée au tribunal ou lors d'investigations, lorsque la personne suspectée admet avoir laissé ses empreintes digitales sur une scène de crime mais prétend l'avoir fait à un autre moment que celui du crime et pour une raison innocente. Toutefois, aucune réponse ne peut actuellement être donnée à cette question, puisqu'aucune méthodologie n'est pour l'heure validée et acceptée par l'ensemble de la communauté forensique. Néanmoins, l'inventaire de cas américains conduit dans cette recherche a montré que les experts fournissent tout de même des témoignages au tribunal concernant l'âge de traces digitales, même si ceux-­‐ci sont majoritairement basés sur des paramètres subjectifs et mal documentés. Il a été relativement aisé d'accéder à des cas américains détaillés, ce qui explique le choix de l'exemple. Toutefois, la problématique de la datation des traces digitales est rencontrée dans le monde entier, et le manque de consensus actuel dans les réponses données souligne la nécessité d'effectuer des études sur le sujet. Le but de la présente recherche est donc d'évaluer la possibilité de développer une méthode de datation objective des traces digitales. Comme les questions entourant la mise au point d'une telle procédure ne sont pas nouvelles, différentes tentatives ont déjà été décrites dans la littérature. Cette recherche les a étudiées de manière critique, et souligne que la plupart des méthodologies reportées souffrent de limitations prévenant leur utilisation pratique. Néanmoins, certaines approches basées sur l'évolution dans le temps de composés intrinsèques aux résidus papillaires se sont montrées prometteuses. Ainsi, un recensement détaillé de la littérature a été conduit afin d'identifier les composés présents dans les traces digitales et les techniques analytiques capables de les détecter. Le choix a été fait de se concentrer sur les composés sébacés détectés par chromatographie gazeuse couplée à la spectrométrie de masse (GC/MS) ou par spectroscopie infrarouge à transformée de Fourier. Des analyses GC/MS ont été menées afin de caractériser la variabilité initiale de lipides cibles au sein des traces digitales d'un même donneur (intra-­‐variabilité) et entre les traces digitales de donneurs différents (inter-­‐variabilité). Ainsi, plusieurs molécules ont été identifiées et quantifiées pour la première fois dans les résidus papillaires. De plus, il a été déterminé que l'intra-­‐variabilité des résidus était significativement plus basse que l'inter-­‐variabilité, mais que ces deux types de variabilité pouvaient être réduits en utilisant différents pré-­‐ traitements statistiques s'inspirant du domaine du profilage de produits stupéfiants. Il a également été possible de proposer un modèle objectif de classification des donneurs permettant de les regrouper dans deux classes principales en se basant sur la composition initiale de leurs traces digitales. Ces classes correspondent à ce qui est actuellement appelé de manière relativement subjective des « bons » ou « mauvais » donneurs. Le potentiel d'un tel modèle est élevé dans le domaine de la recherche en traces digitales, puisqu'il permet de sélectionner des donneurs représentatifs selon les composés d'intérêt. En utilisant la GC/MS et la FTIR, une étude détaillée a été conduite sur les effets de différents facteurs d'influence sur la composition initiale et le vieillissement de molécules lipidiques au sein des traces digitales. Il a ainsi été déterminé que des modèles univariés et multivariés pouvaient être construits pour décrire le vieillissement des composés cibles (transformés en paramètres de vieillissement par pré-­‐traitement), mais que certains facteurs d'influence affectaient ces modèles plus sérieusement que d'autres. En effet, le donneur, le substrat et l'application de techniques de révélation semblent empêcher la construction de modèles reproductibles. Les autres facteurs testés (moment de déposition, pression, température et illumination) influencent également les résidus et leur vieillissement, mais des modèles combinant différentes valeurs de ces facteurs ont tout de même prouvé leur robustesse dans des situations bien définies. De plus, des traces digitales-­‐tests ont été analysées par GC/MS afin d'être datées en utilisant certains des modèles construits. Il s'est avéré que des estimations correctes étaient obtenues pour plus de 60 % des traces-­‐tests datées, et jusqu'à 100% lorsque les conditions de stockage étaient connues. Ces résultats sont intéressants mais il est impératif de conduire des recherches supplémentaires afin d'évaluer les possibilités d'application de ces modèles dans des cas réels. Dans une perspective plus fondamentale, une étude pilote a également été effectuée sur l'utilisation de la spectroscopie infrarouge combinée à l'imagerie chimique (FTIR-­‐CI) afin d'obtenir des informations quant à la composition et au vieillissement des traces digitales. Plus précisément, la capacité de cette technique à mettre en évidence le vieillissement et l'effet de certains facteurs d'influence sur de larges zones de traces digitales a été investiguée. Cette information a ensuite été comparée avec celle obtenue par les spectres FTIR simples. Il en a ainsi résulté que la FTIR-­‐CI était un outil puissant, mais que son utilisation dans l'étude des résidus papillaires à des buts forensiques avait des limites. En effet, dans cette recherche, cette technique n'a pas permis d'obtenir des informations supplémentaires par rapport aux spectres FTIR traditionnels et a également montré des désavantages majeurs, à savoir de longs temps d'analyse et de traitement, particulièrement lorsque de larges zones de traces digitales doivent être couvertes. Finalement, les résultats obtenus dans ce travail ont permis la proposition et discussion d'une approche pragmatique afin d'aborder les questions de datation des traces digitales. Cette approche permet ainsi d'identifier quel type d'information le scientifique serait capable d'apporter aux enquêteurs et/ou au tribunal à l'heure actuelle. De plus, le canevas proposé décrit également les différentes étapes itératives de développement qui devraient être suivies par la recherche afin de parvenir à la validation d'une méthodologie de datation des traces digitales objective, dont les capacités et limites sont connues et documentées. -- "How old is this fingermark?" This question is relatively often raised in trials when suspects admit that they have left their fingermarks on a crime scene but allege that the contact occurred at a time different to that of the crime and for legitimate reasons. However, no answer can be given to this question so far, because no fingermark dating methodology has been validated and accepted by the whole forensic community. Nevertheless, the review of past American cases highlighted that experts actually gave/give testimonies in courts about the age of fingermarks, even if mostly based on subjective and badly documented parameters. It was relatively easy to access fully described American cases, thus explaining the origin of the given examples. However, fingermark dating issues are encountered worldwide, and the lack of consensus among the given answers highlights the necessity to conduct research on the subject. The present work thus aims at studying the possibility to develop an objective fingermark dating method. As the questions surrounding the development of dating procedures are not new, different attempts were already described in the literature. This research proposes a critical review of these attempts and highlights that most of the reported methodologies still suffer from limitations preventing their use in actual practice. Nevertheless, some approaches based on the evolution of intrinsic compounds detected in fingermark residue over time appear to be promising. Thus, an exhaustive review of the literature was conducted in order to identify the compounds available in the fingermark residue and the analytical techniques capable of analysing them. It was chosen to concentrate on sebaceous compounds analysed using gas chromatography coupled with mass spectrometry (GC/MS) or Fourier transform infrared spectroscopy (FTIR). GC/MS analyses were conducted in order to characterize the initial variability of target lipids among fresh fingermarks of the same donor (intra-­‐variability) and between fingermarks of different donors (inter-­‐variability). As a result, many molecules were identified and quantified for the first time in fingermark residue. Furthermore, it was determined that the intra-­‐variability of the fingermark residue was significantly lower than the inter-­‐variability, but that it was possible to reduce both kind of variability using different statistical pre-­‐ treatments inspired from the drug profiling area. It was also possible to propose an objective donor classification model allowing the grouping of donors in two main classes based on their initial lipid composition. These classes correspond to what is relatively subjectively called "good" or "bad" donors. The potential of such a model is high for the fingermark research field, as it allows the selection of representative donors based on compounds of interest. Using GC/MS and FTIR, an in-­‐depth study of the effects of different influence factors on the initial composition and aging of target lipid molecules found in fingermark residue was conducted. It was determined that univariate and multivariate models could be build to describe the aging of target compounds (transformed in aging parameters through pre-­‐ processing techniques), but that some influence factors were affecting these models more than others. In fact, the donor, the substrate and the application of enhancement techniques seemed to hinder the construction of reproducible models. The other tested factors (deposition moment, pressure, temperature and illumination) also affected the residue and their aging, but models combining different values of these factors still proved to be robust. Furthermore, test-­‐fingermarks were analysed with GC/MS in order to be dated using some of the generated models. It turned out that correct estimations were obtained for 60% of the dated test-­‐fingermarks and until 100% when the storage conditions were known. These results are interesting but further research should be conducted to evaluate if these models could be used in uncontrolled casework conditions. In a more fundamental perspective, a pilot study was also conducted on the use of infrared spectroscopy combined with chemical imaging in order to gain information about the fingermark composition and aging. More precisely, its ability to highlight influence factors and aging effects over large areas of fingermarks was investigated. This information was then compared with that given by individual FTIR spectra. It was concluded that while FTIR-­‐ CI is a powerful tool, its use to study natural fingermark residue for forensic purposes has to be carefully considered. In fact, in this study, this technique does not yield more information on residue distribution than traditional FTIR spectra and also suffers from major drawbacks, such as long analysis and processing time, particularly when large fingermark areas need to be covered. Finally, the results obtained in this research allowed the proposition and discussion of a formal and pragmatic framework to approach the fingermark dating questions. It allows identifying which type of information the scientist would be able to bring so far to investigators and/or Justice. Furthermore, this proposed framework also describes the different iterative development steps that the research should follow in order to achieve the validation of an objective fingermark dating methodology, whose capacities and limits are well known and properly documented.

Biological interpretation of genome-wide association studies using predicted gene functions.

The main challenge for gaining biological insights from genetic associations is identifying which genes and pathways explain the associations. Here we present DEPICT, an integrative tool that employs predicted gene functions to systematically prioritize the most likely causal genes at associated loci, highlight enriched pathways and identify tissues/cell types where genes from associated loci are highly expressed. DEPICT is not limited to genes with established functions and prioritizes relevant gene sets for many phenotypes.

Evaluation of steroidomics by liquid chromatography hyphenated to mass spectrometry as a powerful analytical strategy for measuring human steroid perturbations.

This review presents the evolution of steroid analytical techniques, including gas chromatography coupled to mass spectrometry (GC-MS), immunoassay (IA) and targeted liquid chromatography coupled to mass spectrometry (LC-MS), and it evaluates the potential of extended steroid profiles by a metabolomics-based approach, namely steroidomics. Steroids regulate essential biological functions including growth and reproduction, and perturbations of the steroid homeostasis can generate serious physiological issues; therefore, specific and sensitive methods have been developed to measure steroid concentrations. GC-MS measuring several steroids simultaneously was considered the first historical standard method for analysis. Steroids were then quantified by immunoassay, allowing a higher throughput; however, major drawbacks included the measurement of a single compound instead of a panel and cross-reactivity reactions. Targeted LC-MS methods with selected reaction monitoring (SRM) were then introduced for quantifying a small steroid subset without the problems of cross-reactivity. The next step was the integration of metabolomic approaches in the context of steroid analyses. As metabolomics tends to identify and quantify all the metabolites (i.e., the metabolome) in a specific system, appropriate strategies were proposed for discovering new biomarkers. Steroidomics, defined as the untargeted analysis of the steroid content in a sample, was implemented in several fields, including doping analysis, clinical studies, in vivo or in vitro toxicology assays, and more. This review discusses the current analytical methods for assessing steroid changes and compares them to steroidomics. Steroids, their pathways, their implications in diseases and the biological matrices in which they are analysed will first be described. Then, the different analytical strategies will be presented with a focus on their ability to obtain relevant information on the steroid pattern. The future technical requirements for improving steroid analysis will also be presented.

Rapid analysis of multiclass antibiotic residues and some of their metabolites in hospital, urban wastewater and river water by ultra-highperformance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry

The present work describes the development of a fast and robust analytical method for the determination of 53 antibiotic residues, covering various chemical groups and some of their metabolites, in environmental matrices that are considered important sources of antibiotic pollution, namely hospital and urban wastewaters, as well as in river waters. The method is based on automated off-line solid phase extraction (SPE) followed by ultra-high-performance liquid chromatography coupled to quadrupole linear ion trap tandem mass spectrometry (UHPLC–QqLIT). For unequivocal identification and confirmation, and in order to fulfill EU guidelines, two selected reaction monitoring (SRM) transitions per compound are monitored (the most intense one is used for quantification and the second one for confirmation). Quantification of target antibiotics is performed by the internal standard approach, using one isotopically labeled compound for each chemical group, in order to correct matrix effects. The main advantages of the method are automation and speed-up of sample preparation, by the reduction of extraction volumes for all matrices, the fast separation of a wide spectrum of antibiotics by using ultra-high-performance liquid chromatography, its sensitivity (limits of detection in the low ng/L range) and selectivity (due to the use of tandem mass spectrometry) The inclusion of β-lactam antibiotics (penicillins and cephalosporins), which are compounds difficult to analyze in multi-residue methods due to their instability in water matrices, and some antibiotics metabolites are other important benefits of the method developed. As part of the validation procedure, the method developed was applied to the analysis of antibiotics residues in hospital, urban influent and effluent wastewaters as well as in river water samples

Interrater variability of EEG interpretation in comatose cardiac arrest patients.

OBJECTIVE: EEG is widely used to predict outcome in comatose cardiac arrest patients, but its value has been limited by lack of a uniform classification. We used the EEG terminology proposed by the American Clinical Neurophysiology Society (ACNS) to assess interrater variability in a cohort of cardiac arrest patients included in the Target Temperature Management trial. The main objective was to evaluate if malignant EEG-patterns could reliably be identified. METHODS: Full-length EEGs from 103 comatose cardiac arrest patients were interpreted by four EEG-specialists with different nationalities who were blinded for patient outcome. Percent agreement and kappa (κ) for the categories in the ACNS EEG terminology and for prespecified malignant EEG-patterns were calculated. RESULTS: There was substantial interrater agreement (κ 0.71) for highly malignant patterns and moderate agreement (κ 0.42) for malignant patterns. Substantial agreement was found for malignant periodic or rhythmic patterns (κ 0.72) while agreement for identifying an unreactive EEG was fair (κ 0.26). CONCLUSIONS: The ACNS EEG terminology can be used to identify highly malignant EEG-patterns in post cardiac arrest patients in an international context with high reliability. SIGNIFICANCE: The establishment of strict criteria with high transferability between interpreters will increase the usefulness of routine EEG to assess neurological prognosis after cardiac arrest.

Indirect comparison meta-analysis of two enoxaparin regimens in patients undergoing major orthopaedic surgery. Impact on the interpretation of thromboprophylactic effects of new anticoagulant drugs.

Two enoxaparin dosage regimens are used as comparators to evaluate new anticoagulants for thromboprophylaxis in patients undergoing major orthopaedic surgery, but so far no satisfactory direct comparison between them has been published. Our objective was to compare the efficacy and safety of enoxaparin 3,000 anti-Xa IU twice daily and enoxaparin 4,000 anti-Xa IU once daily in this clinical setting by indirect comparison meta-analysis, using Bucher's method. We selected randomised controlled trials comparing another anticoagulant, placebo (or no treatment) with either enoxaparin regimen for venous thromboembolism prophylaxis after hip or knee replacement or hip fracture surgery, provided that the second regimen was assessed elsewhere versus the same comparator. Two authors independently evaluated study eligibility, extracted the data, and assessed the risk of bias. The primary efficacy outcome was the incidence of venous thomboembolism. The main safety outcome was the incidence of major bleeding. Overall, 44 randomised comparisons in 56,423 patients were selected, 35 being double-blind (54,117 patients). Compared with enoxaparin 4,000 anti-Xa IU once daily, enoxaparin 3,000 anti-Xa IU twice daily was associated with a reduced risk of venous thromboembolism (relative risk [RR]: 0.53, 95% confidence interval [CI]: 0.40 to 0.69), but an increased risk of major bleeding (RR: 2.01, 95% CI: 1.23 to 3.29). In conclusion, when interpreting the benefit-risk ratio of new anticoagulant drugs versus enoxaparin for thromboprophylaxis after major orthopaedic surgery, the apparently greater efficacy but higher bleeding risk of the twice-daily 3,000 anti-Xa IU enoxaparin regimen compared to the once-daily 4,000 anti-Xa IU regimen should be taken into account.

A practical guide for the formulation of propositions in the bayesian approach to DNA evidence interpretation in an adversarial environment

The interpretation of complex DNA profiles is facilitated by a Bayesian approach. This approach requires the development of a pair of propositions: one aligned to the prosecution case and one to the defense case. This note explores the issue of proposition setting in an adversarial environment by a series of examples. A set of guidelines generalize how to formulate propositions when there is a single person of interest and when there are multiple individuals of interest. Additional explanations cover how to handle multiple defense propositions, relatives, and the transition from subsource level to activity level propositions. The propositions depend on case information and the allegations of each of the parties. The prosecution proposition is usually known. The authors suggest that a sensible proposition is selected for the defense that is consistent with their stance, if available, and consistent with a realistic defense if their position is not known.

Systematic evaluation of matrix effects in hydrophilic interaction chromatography versus reversed phase liquid chromatography coupled to mass spectrometry.

Reversed phase liquid chromatography (RPLC) coupled to mass spectrometry (MS) is the gold standard technique in bioanalysis. However, hydrophilic interaction chromatography (HILIC) could represent a viable alternative to RPLC for the analysis of polar and/or ionizable compounds, as it often provides higher MS sensitivity and alternative selectivity. Nevertheless, this technique can be also prone to matrix effects (ME). ME are one of the major issues in quantitative LC-MS bioanalysis. To ensure acceptable method performance (i.e., trueness and precision), a careful evaluation and minimization of ME is required. In the present study, the incidence of ME in HILIC-MS/MS and RPLC-MS/MS was compared for plasma and urine samples using two representative sets of 38 pharmaceutical compounds and 40 doping agents, respectively. The optimal generic chromatographic conditions in terms of selectivity with respect to interfering compounds were established in both chromatographic modes by testing three different stationary phases in each mode with different mobile phase pH. A second step involved the assessment of ME in RPLC and HILIC under the best generic conditions, using the post-extraction addition method. Biological samples were prepared using two different sample pre-treatments, i.e., a non-selective sample clean-up procedure (protein precipitation and simple dilution for plasma and urine samples, respectively) and a selective sample preparation, i.e., solid phase extraction for both matrices. The non-selective pretreatments led to significantly less ME in RPLC vs. HILIC conditions regardless of the matrix. On the contrary, HILIC appeared as a valuable alternative to RPLC for plasma and urine samples treated by a selective sample preparation. Indeed, in the case of selective sample preparation, the compounds influenced by ME were different in HILIC and RPLC, and lower and similar ME occurrence was generally observed in RPLC vs. HILIC for urine and plasma samples, respectively. The complementary of both chromatographic modes was also demonstrated, as ME was observed only scarcely for urine and plasma samples when selecting the most appropriate chromatographic mode.

Fast and sensitive supercritical fluid chromatography - tandem mass spectrometry multi-class screening method for the determination of doping agents in urine.

This study shows the possibility offered by modern ultra-high performance supercritical fluid chromatography combined with tandem mass spectrometry in doping control analysis. A high throughput screening method was developed for 100 substances belonging to the challenging classes of anabolic agents, hormones and metabolic modulators, synthetic cannabinoids and glucocorticoids, which should be detected at low concentrations in urine. To selectively extract these doping agents from urine, a supported liquid extraction procedure was implemented in a 48-well plate format. At the tested concentration levels ranging from 0.5 to 5 ng/mL, the recoveries were better than 70% for 48-68% of the compounds and higher than 50% for 83-87% of the tested substances. Due to the numerous interferences related to isomers of steroids and ions produced by the loss of water in the electrospray source, the choice of SFC separation conditions was very challenging. After careful optimization, a Diol stationary phase was employed. The total analysis time for the screening assay was only 8 min, and interferences as well as susceptibility to matrix effect (ME) were minimized. With the developed method, about 70% of the compounds had relative ME within the range ±20%, at a concentration of 1 and 5 ng/mL. Finally, limits of detection achieved with the above-described strategy including 5-fold preconcentration were below 0.1 ng/mL for the majority of the tested compounds. Therefore, LODs were systematically better than the minimum required performance levels established by the World anti-doping agency, except for very few metabolites.

Direct Interrogation of Viral Peptides Presented by the Class I HLA of HIV-Infected T Cells

Identification of CD8+ cytotoxic T lymphocyte (CTL) epitopes has traditionally relied upon testing of overlapping peptide libraries for their reactivity with T cells in vitro. Here, we pursued deep ligand sequencing (DLS) as an alternative method of directly identifying those ligands that are epitopes presented to CTLs by the class I human leukocyte antigens (HLA) of infected cells. Soluble class I HLA-A*11:01 (sHLA) was gathered from HIV-1 NL4-3-infected human CD4+ SUP-T1 cells. HLA-A*11:01 harvested from infected cells was immunoaffinity purified and acid boiled to release heavy and light chains from peptide ligands that were then recovered by size-exclusion filtration. The ligands were first fractionated by high-pH high-pressure liquid chromatography and then subjected to separation by nano-liquid chromatography (nano-LC)–mass spectrometry (MS) at low pH. Approximately 10 million ions were selected for sequencing by tandem mass spectrometry (MS/MS). HLA-A*11:01 ligand sequences were determined with PEAKS software and confirmed by comparison to spectra generated from synthetic peptides. DLS identified 42 viral ligands presented by HLA-A*11:01, and 37 of these were previously undetected. These data demonstrate that (i) HIV-1 Gag and Nef are extensively sampled, (ii) ligand length variants are prevalent, particularly within Gag and Nef hot spots where ligand sequences overlap, (iii) noncanonical ligands are T cell reactive, and (iv) HIV-1 ligands are derived from de novo synthesis rather than endocytic sampling. Next-generation immunotherapies must factor these nascent HIV-1 ligand length variants and the finding that CTL-reactive epitopes may be absent during infection of CD4+ T cells into strategies designed to enhance T cell immunity.